Evaluation of the Safety and Effectiveness of the Oculeve Intranasal Lacrimal Neurostimulator in Patients With Dry Eye

Completed · Not applicable

Conditions studied: Dry Eye Syndromes

In brief

The purpose of this study was to evaluate the safety and effectiveness of the Intranasal Tear Neurostimulator applied intranasally compared with the same device applied extranasally (control) in treating the symptoms of dry eye exacerbated by the Controlled Adverse Environment (CAE) Model.

Key facts

Study ID

NCT02313454

Run by

Allergan

People needed

21

Starts

2014-11-17

Expected to finish

2015-04-08

Last updated by the study team

2020-01-31

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Bilateral dry eyes
• Capable of providing written informed consent

You may not qualify if…

• Chronic or recurring epistaxis (nosebleeds)
• Uncontrolled systemic disease
• Blood coagulation disorder
• Females who are pregnant, nursing or planning a pregnancy

Where it is running

• Andover Eye Associates — Andover, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.